Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
3.905
-0.305 (-7.24%)
Mar 31, 2025, 1:40 PM EDT - Market open
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $221.66 million as of March 31, 2025. Its market cap has increased by 47.69% in one year.
Market Cap
221.66M
Enterprise Value
-4.17M
1-Year Change
47.69%
Ranking
Category
Stock Price
$3.91
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $221.66M, a decrease of -89.95%. That is a compound annual growth rate of -43.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 238.97M | -31.60% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |